Skip to main content
. 2015 Oct 16;21(1):10.18553/jmcp.2015.21.1.66. doi: 10.18553/jmcp.2015.21.1.66

TABLE 1.

General Characteristics of Study Participants at Baseline

Variable Intervention Group (n = 97) Control Group (n = 97) P Valuea,b
Female gender, n (%) 61.0 (62.9) 60.0 (61.8) 0.882
Mean age, years (SD) 65.3 (5.8) 65.3 (5.8) 0.990
Mean monthly family income, $ (SD) 314.9 (99.1) 317.8 (101.8) 0.320
Incomplete elementary school, n (%) 76.0 (78.4) 75.0 (77.4) 0.926
Mean SBP, mmHg (SD) 156.7 (21.8) 155.9 (20.8) 0.788
Mean DBP, mmHg (SD) 106.6 (17.7) 108.7 (16.9) 0.363
Mean fasting glucose, mg/dL (SD) 135.1 (55.6) 135.8 (55.4) 0.932
Mean hemoglobin A1c, % (SD)c 7.7 (0.5) 7.7 (0.5) 0.691
Mean triglycerides, mg/dL (SD) 206.0 (134.8) 206.5 (134.6) 0.977
Mean LDL cholesterol, mg/dL (SD) 112.4 (12.7) 112.1 (12.7) 0.902
Mean HDL cholesterol, mg/dL (SD) 55.5 (8.5) 54.9 (6.6) 0.511
Mean total cholesterol, mg/dL (SD) 202.5 (35.7) 202.0 (35.4) 0.915
Mean 10-year risk assessment for coronary heart disease, % (SD)d 6.8 (4.5) 6.9 (4.5) 0.895
Mean diagnosed diseases, n (SD) 2.4 (1.3) 2.4 (1.3) 0.986
Patients diagnosed with hypertension, n (%)d,e 46.0 (47.4) 44.0 (45.4) 0.776
Patients diagnosed with diabetes, n (%)e 17.0 (17.5) 18.0 (18.5) 0.854
Patients presenting with diabetes and hypertension, n (%) 34.0 (35.1) 35.0 (36.1) 0.882
Mean number of drugs for chronic use, n (SD) 3.3 (1.7) 3.3 (1.7) 0.174

Note: Monetary values are presented in U.S. dollars.

aThe χ2 test and independent-sample Student t-test were used as appropriate.

b P < 0.05 was considered statistically significant.

c Only patients with a diagnosis of diabetes were subjected to this exam.

d 10-year risk assessment for coronary heart disease was performed using the Framingham scoring method.32

e Patients presenting with hypertension or diabetes.

DBP = diastolic blood pressure; HDL = high-density lipoprotein; LDL = low-density lipoprotein; mg/dL = milligrams per deciliter; mmHg = millimeter of mercury; SBP = systolic blood pressure; SD = standard deviation.